PL2979694T3 - Kwas dimerkaptobursztynowy do leczenia zakażeń wywołanych przez bakterie wielolekooporne - Google Patents

Kwas dimerkaptobursztynowy do leczenia zakażeń wywołanych przez bakterie wielolekooporne

Info

Publication number
PL2979694T3
PL2979694T3 PL14306230T PL14306230T PL2979694T3 PL 2979694 T3 PL2979694 T3 PL 2979694T3 PL 14306230 T PL14306230 T PL 14306230T PL 14306230 T PL14306230 T PL 14306230T PL 2979694 T3 PL2979694 T3 PL 2979694T3
Authority
PL
Poland
Prior art keywords
treatment
bacterial infections
multidrug resistant
resistant bacterial
dimercaptosuccinic acid
Prior art date
Application number
PL14306230T
Other languages
English (en)
Inventor
Patrice Nordmann
Laurent Poirel
Delphine GIRLICH
Original Assignee
Univ De Fribourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ De Fribourg filed Critical Univ De Fribourg
Publication of PL2979694T3 publication Critical patent/PL2979694T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14306230T 2014-08-01 2014-08-01 Kwas dimerkaptobursztynowy do leczenia zakażeń wywołanych przez bakterie wielolekooporne PL2979694T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14306230.5A EP2979694B1 (en) 2014-08-01 2014-08-01 Dimercaptosuccinic acid for the treatment of multidrug resistant bacterial infections

Publications (1)

Publication Number Publication Date
PL2979694T3 true PL2979694T3 (pl) 2019-04-30

Family

ID=51298681

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14306230T PL2979694T3 (pl) 2014-08-01 2014-08-01 Kwas dimerkaptobursztynowy do leczenia zakażeń wywołanych przez bakterie wielolekooporne

Country Status (5)

Country Link
EP (1) EP2979694B1 (pl)
DK (1) DK2979694T3 (pl)
ES (1) ES2704695T3 (pl)
PL (1) PL2979694T3 (pl)
PT (1) PT2979694T (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115969823B (zh) * 2021-06-04 2025-04-08 中国人民解放军南部战区总医院 β-内酰胺酶抑制剂
WO2025257398A1 (en) * 2024-06-14 2025-12-18 Universite De Tours Dicarboxylic acids and esters thereof for use in the treatment of a viral lung infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2750501B1 (en) * 2011-08-31 2018-07-11 Organic Medical Ventures, L.L.C. Transdermal venous access locking solutions

Also Published As

Publication number Publication date
DK2979694T3 (en) 2019-01-28
PT2979694T (pt) 2019-01-23
ES2704695T3 (es) 2019-03-19
EP2979694B1 (en) 2018-10-17
EP2979694A1 (en) 2016-02-03

Similar Documents

Publication Publication Date Title
IL279627A (en) A method for treating depression
IL247259A0 (en) Organic monobactam compounds for the treatment of bacterial infections
IL247515A0 (en) Snekribirock for the treatment of leprosy
EP3102225A4 (en) Combination therapy for treatment of hbv infections
SMT201900172T1 (it) Ammino triazoli sostituiti utili come inibitori della chitinasi umana
ZA201703245B (en) Combination therapy for treatment of resistant bacterial infections
SG11201609652RA (en) Treatment of polybacterials infections
AP2016009497A0 (en) Process for the treatment of high sulphate waters
EP3227276A4 (en) Combinations for the treatment of neuroblastoma
EP3236988B8 (en) Pharmaceutical compositions for the treatment of bacterial superinfections post-influenza
ZA201608307B (en) Process for the purification of l-alpha-glycerophosphorylcholine
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
PT2979694T (pt) Ácido dimercaptossuccínico para o tratamento de infeções bacterianas resistentes a multifármacos
SG11201703330YA (en) Iminosugars useful for the treatment of viral diseases
PL2937084T3 (pl) Sposób leczenia hipercholesterolemii
PL2975004T3 (pl) Obróbka kwasowych ścieków
ZA201901948B (en) Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections
IL252237A0 (en) Compounds for the treatment of cancer
PT3166604T (pt) Agentes para o tratamento de doenças infeciosas retrovirais
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
GB201408752D0 (en) Arthritis treatment
GB201409434D0 (en) Combinations useful for the treatment of bacterial infectious diseases
AU2014901912A0 (en) Compounds for the treatment of bacterial infections
AU2014901885A0 (en) Compounds for the treatment of antibacterial infections
HK1238246A1 (en) Iminosugars useful for the treatment of viral diseases